ישראל - עברית - Ministry of Health

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - אבקה וממס להכנת תמיסה להזרקה - von willebrand factor 1000 iu/vial; factor viii (human) 1000 iu/vial - coagulation factor viii

ישראל - עברית - Ministry of Health

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - אבקה וממס להכנת תמיסה להזרקה - von willebrand factor 500 iu/vial; factor viii (human) 500 iu/vial - coagulation factor viii

ישראל - עברית - Ministry of Health

dover medical & scientific equipment ltd, israel - factor ix - אבקה וממס להכנת תמיסה להזרקה - factor ix 100 iu/ml - coagulation factor ix - coagulation factor ix - treatment and prophylaxis of bleeding in patients with haemophilia b (congenital factor ix deficiency).

ישראל - עברית - Ministry of Health

dover medical & scientific equipment ltd, israel - factor ix - אבקה וממס להכנת תמיסה להזרקה - factor ix 100 iu/ml - coagulation factor ix - coagulation factor ix - treatment and prophylaxis of bleeding in patients with haemophilia b (congenital factor ix deficiency).

ישראל - עברית - Ministry of Health

dover medical & scientific equipment ltd, israel - albumin human; plasma protein fraction - תמיסה לאינפוזיה - albumin human 50 g / 1000 ml; plasma protein fraction 96 % - albumin - albumin - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate.the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on the official recommendations

ישראל - עברית - Ministry of Health

dover medical & scientific equipment ltd, israel - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 50 mg/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy in: • primary immunodeficiency syndromes such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia - common variable immunodeficiency - severe combined immunodeficiency - wiskott aldrich syndrome. • children with congenital aids and recurrent bacterial infections. immunomodulatory effect: • idiopathic thrombocytopenic purpura (itp) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count. • guillain barre syndrome. • kawasaki disease. allogeneic bone marrow transplantation.• myeloma or chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.

ישראל - עברית - Ministry of Health

dover medical & scientific equipment ltd, israel - factor viii - אבקה וממס להכנת תמיסה להזרקה - factor viii 1000 iu/vial - coagulation factor viii

ישראל - עברית - Ministry of Health

dover medical & scientific equipment ltd, israel - factor viii - אבקה וממס להכנת תמיסה להזרקה - factor viii 500 iu/vial - coagulation factor viii

ישראל - עברית - Ministry of Health

dover medical & scientific equipment ltd, israel - coagulation factor ii (human); coagulation factor ix (human- rfixfc); coagulation factor vii (human); coagulation factor x (human); protein; protein c; protein s antigen - אבקה וממס להכנת תמיסה לאינפוזיה - coagulation factor ix (human- rfixfc) 25 iu/ml; coagulation factor ii (human) 14 - 38 iu/ml; coagulation factor vii (human) 9 - 24 iu/ml; coagulation factor x (human) 18 - 30 iu/ml; protein 13 - 41 mg/ml; protein c 13 - 31 iu/ml; protein s antigen 12 - 32 iu/ml - coagulation factor ix, ii, vii and x in combination

ישראל - עברית - Ministry of Health

dover medical & scientific equipment ltd, israel - albumin human; plasma protein fraction - תמיסה לאינפוזיה - albumin human 200 g / 1000 ml; plasma protein fraction 96 % - albumin